Cargando…

5589252 SYSTEMATIC LITERATURE REVIEW OF HEALTH-RELATED QUALITY OF LIFE BURDEN IN PATIENTS ACROSS THE SPECTRUM OF THALASSEMIA

Detalles Bibliográficos
Autores principales:	Musallam, K.M., Vinals, L., Gilroy, K., Rizzo, M., Tam, C., Lombard, L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2023
Materias:	Oral Presentations
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10112595/ http://dx.doi.org/10.1097/01.HS9.0000928220.97786.b2

Ejemplares similares

PB2233: SYSTEMATIC LITERATURE REVIEW OF HEALTH-RELATED QUALITY OF LIFE BURDEN IN PATIENTS ACROSS THE SPECTRUM OF THALASSEMIA
por: Musallam, K. M., et al.
Publicado: (2022)

5610611 REAL-WORLD EVIDENCE CHARACTERIZING THE BURDEN OF DISEASE IN ALPHA AND BETA THALASSEMIA PATIENTS IN THE USA: AN INTERIM ANALYSIS
por: Musallam, K.M., et al.
Publicado: (2023)

S111: BRAIN PERFUSION CHANGES IN BETA-THALASSEMIA
por: Manara, R, et al.
Publicado: (2022)

S124: ADVERSE EVENTS FOLLOWING COVID-19 VACCINATION IN TRANSFUSION-DEPENDENT -THALASSEMIA PATIENTS
por: Delaporta, P, et al.
Publicado: (2022)

Cardiac T2* magnetic resonance for prediction of cardiac complications in thalassemia major
por: Kirk, Paul, et al.
Publicado: (2009)

S106: LONG-TERM FOLLOW-UP OF BETA-THALASSEMIA PATIENTS TREATED WITH HEMATOPOIETIC STEM CELL GENE THERAPY
por: Marktel, S, et al.
Publicado: (2022)

S104: A SEVERE MOUSE MODEL OF ALPHA-THALASSEMIA SHOWS ABNORMAL IRON METABOLISM, ERYTHROPOIESIS AND COAGULATION, AND CAN BE RESCUED BY A NOVEL GENE THERAPY APPROACH
por: Chappell, M, et al.
Publicado: (2022)

O011 Effect of Continuous Positive Airway Pressure on Quality of Life and Treatment Burden in Children with Obstructive Sleep Apnoea
por: Nisbet, L, et al.
Publicado: (2022)

S116: LONG-TERM EFFICACY AND SAFETY OF THE ORAL PYRUVATE KINASE ACTIVATOR MITAPIVAT IN ADULTS WITH NON—TRANSFUSION-DEPENDENT ALPHA- OR BETA-THALASSEMIA
por: Kuo, K, et al.
Publicado: (2022)

5612617 EFFICACY AND SAFETY OF A SINGLE DOSE OF EXAGAMGLOGENE AUTOTEMCEL FOR TRANSFUSION-DEPENDENT-THALASSEMIA AND SEVERE SICKLE CELL DISEASE
por: de la Fuente, J., et al.
Publicado: (2023)

Shape and weight concern as a moderator of program outcomes from the Prevention Across the Spectrum RCT
por: Wilksch, Simon, et al.
Publicado: (2015)

S123: SAFETY AND EFFICACY OF EARLY-START DEFERIPRONE IN INFANTS AND YOUNG CHILDREN WITH BETA-THALASSEMIA (START STUDY)
por: Elalfy, M, et al.
Publicado: (2022)

Determine the myocardial T2* cut-off value in thalassemia using gaussian mixtures models
por: He, Taigang, et al.
Publicado: (2012)

S103: TRIAL IN PROGRESS: A PHASE 2, OPEN-LABEL STUDY EVALUATING THE SAFETY AND EFFICACY OF THE PKR ACTIVATOR ETAVOPIVAT (FT-4202) IN PATIENTS WITH THALASSEMIA OR SICKLE CELL DISEASE
por: Lal, A., et al.
Publicado: (2022)

S101: COMBINATION OF A LUSPATERCEPT-LIKE DRUG (RAP-GRL) AND TMPRSS6-ASO IS SUPERIOR TO EITHER DRUG ALONE FOR CORRECTING β-THALASSEMIA
por: Guerra, A., et al.
Publicado: (2022)

Prevention across the spectrum: findings from an RCT of three programs aimed at reducing risk factors for both eating disorders and obesity
por: Wilksch, Simon, et al.
Publicado: (2013)

An RCT of three programs aimed at reducing risk factors for both eating disorders and obesity: outcomes from the Prevention Across the Spectrum study
por: Wilksch, Simon, et al.
Publicado: (2014)

OA03.04. An assessment of the effectiveness of acupuncture for the Trauma Spectrum Response: results of a rapid evidence assessment of the literature (REAL)
por: Lee, C, et al.
Publicado: (2012)

Thalassemias: can we reduce the national burden?
por: Colah, Roshan
Publicado: (2014)

O036 Measuring Sleep-wake State Discrepancy in the Home across Multiple Nights
por: Bensen-Boakes, D, et al.
Publicado: (2023)

A T2* MRI prospective survey on heart iron in thalassemia major patients treated with deferasirox versus deferiprone and desferrioxamine in monotherapy
por: Pepe, Alessia, et al.
Publicado: (2011)

Prospective comparison on cardiac iron by MR in thalassemia major patients treated with combination deferipron-desferrioxamine versus deferipron and desferrioxamine in monoterapy
por: Pepe, Alessia, et al.
Publicado: (2011)

P482 Burden of serious fungal infections in India
por: Ray, Animesh, et al.
Publicado: (2022)

Ultrafast CMR to deliver high volume screening of an at risk thalassemia population in the developing world: preliminary results from the TIC-TOC study (Thailand and UK international collaboration in thalassaemia using an optimised ultrafast CMR protocol)
por: Abdel-Gadir, Amna, et al.
Publicado: (2016)

A simple and reliable tool to quantify calcium burden of ascending aorta
por: Gatta, E, et al.
Publicado: (2013)

14.1 Clinical spectrum and outcome in 100 children with positive antiphospholipid antibodies
por: Rozic, M, et al.
Publicado: (2008)

The clinical spectrum of HTLV-1 infection
por: Tanajura, Davi, et al.
Publicado: (2015)

Initiation of statin therapy halts progression of atherosclerotic plaque burden in peripheral arterial disease
por: West, Amy M, et al.
Publicado: (2009)

Increasing burden of E. coli bacteraemia and changing epidemiology
por: Wilson, J, et al.
Publicado: (2011)

Health needs assessment of musculoskeletal conditions: an international bone and joint burden of disease study
por: Khaltaev, N, et al.
Publicado: (2004)

S273: LONG-TERM ERYTHROID RESPONSE DATA FROM PATIENTS (PTS) WITH NON-TRANSFUSION-DEPENDENT ΒETA-THALASSEMIA (NTDT) RECEIVING LUSPATERCEPT IN THE BEYOND TRIAL
por: Taher, Ali T., et al.
Publicado: (2023)

A decade of anti-IL-1 therapy in CAPS - a spectrum of efficacy in this spectrum of diseases
por: Lane, T, et al.
Publicado: (2015)

Thalassemia and Venous Thromboembolism
por: Succar, Julien, et al.
Publicado: (2011)

Neonatal aortic coarctation: a spectrum of anatomic lesions repaired trough left thoracotomy in 22 years experience
por: Angeli, E, et al.
Publicado: (2013)

Parallel dysregulation across psychoimmunological and cardiovascular response systems in HIV+ outpatients
por: Temoshok, Lydia R, et al.
Publicado: (2006)

Genotype-phenotype: correlations and emerging spectrum
por: Reuser, Arnold
Publicado: (2013)

5610224 THE USE OF LUSPATERCEPT IN PATIENTS WITH β -THALASSAEMIA AND MULTIPLE SYSTEMIC COMPLICATIONS INCREASES HEMOGLOBIN LEVEL, DECREASES TRANSFUSION BURDEN, AND IS UNAFFECTED BY COMPLICATIONS. SINGLE THALASSEMIA AND SICKLE CELL DEPARTEMENT’S EXPERIENCE.
por: Manganas, K.M., et al.
Publicado: (2023)

Assessing the burden of musculoskeletal conditions: a joint World Health Organization–Bone and Joint Decade project
por: Khaltaev, N, et al.
Publicado: (2003)

5610692 PAIN BURDEN PREDICTS EXECUTIVE FUNCTION IN PAEDIATRIC PATIENTS WITH SICKLE CELL DISEASE
por: Chen, Y., et al.
Publicado: (2023)

Abnormal functional responses of osteoblasts to leptin in adolescent idiopathic scoliosis
por: Tam, Elisa MS, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_d7o8566pccu212m4ln0calcuqr